Search results
2 dni temu · Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the U.S. drugmaker also flagged a second straight ...
2 dni temu · Erik S. Lesser/Getty Images News. Merck (NYSE:MRK) beat Street forecasts with its Q3 2024 revenue on Thursday as its blockbuster cancer therapy Keytruda continued to drive sales growth while its ...
1 dzień temu · Merck & Company (MRK) Company Description: Merck & Co., Inc. develops pharmaceutical and vaccine products. It also offers healthcare solutions and vaccines addressing animal health. The company ...
Get the latest Merck & Co., Inc. (MRK) stock news and headlines to help you in your trading and investing decisions.
2 dni temu · Merck’s stock falls as mixed full-year outlook offsets a quarterly earnings beat. Photo: Getty Images. Merck & Co. Inc.’s stock fell 3% Thursday, after the drug company beat profit and sales ...
2 dni temu · Merck is expecting adjusted operating costs to range from $27.8 billion to $28.3 billion, up from prior guidance of $26.8 billion to $27.6 billion. CFRA downgraded the stock to hold from buy and ...
25 paź 2024 · MRK. Merck MRK will report its third-quarter earnings on Oct. 31, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $16.54 billion and $1.54 per share ...
